This event is co-organised by CRE REDUCE, UQ and CHU Nîmes.
Programme
Date: 3 - 5.30pm, Tuesday 27 October 2020
Antimicrobial susceptibility testing of microbial pathogens is a core and essential component of a clinical microbiological laboratory's guidance for optimal therapy. Clinicians at the bedside are reliant on knowledge of whether a microbial isolate is S for success! However, EUCAST has changed the definitions of susceptibility testing categories S, I and R. The purpose of this meeting is to detail these changes and address implications for implementation and reporting.
Speakers include Prof John Turnidge - EUCAST Scientific Secretary and ACSQHC Senior Clinical Advisor (Adelaide), Prof Gunnar Kahlmeter - MD, EUCAST Steering committee and Head of the EUCAST Development Laboratory (Sweden), and Prof Jean-Philippe Lavigne from Centre Hospitalier Régional Universitaire de Nîmes (France).
| Time | Topic | Speaker/Facilitator |
|---|---|---|
| 1500-1545 | Susceptibility testing - A European perspective
| Prof Jean-Philippe Lavigne Moderator: Prof Jason Roberts |
| 1545-1630 | EUCAST updates - putting I first
| Prof Gunnar Kahlmeter and Prof John Turnidge Moderator: Dr Andrew Henderson |
| 1630-1715 | Q&A session | Moderators: Dr Andrew Henderson and Dr Patrick Harris |
| 1730 | Close | |